Selected research
Industry Growth & Trends
Global Injected Veterinary Pain Management Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Injected Veterinary Pain Management Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Injected Veterinary Pain Management Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Injected Veterinary Pain Management Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Injected Veterinary Pain Management Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Injected Veterinary Pain Management Drugs include Zoetis, Merck & Co, Medtronic, Lilly, Baxter, Norbrook Laboratories, Halyard, Forest Laboratories and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Injected Veterinary Pain Management Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Injected Veterinary Pain Management Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Injected Veterinary Pain Management Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Injected Veterinary Pain Management Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Injected Veterinary Pain Management Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Injected Veterinary Pain Management Drugs Market by Company
Zoetis
Merck & Co
Medtronic
Lilly
Baxter
Norbrook Laboratories
Halyard
Forest Laboratories
Endo International
Elanco
Ceva Sante Animale
Bostonscientific
Boehringer Ingelheim
Bayer Pharma AG
Injected Veterinary Pain Management Drugs Segment by Type
Sedatives
Local Anesthetics
Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
Opioids
α2-Adrenergic Agonists
Other
Injected Veterinary Pain Management Drugs Segment by Application
Veterinary Clinics
Veterinary Hospitals
For Retail
Others
Injected Veterinary Pain Management Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injected Veterinary Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injected Veterinary Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injected Veterinary Pain Management Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injected Veterinary Pain Management Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Injected Veterinary Pain Management Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sedatives
- Local Anesthetics
- Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
- Opioids
- α2-Adrenergic Agonists
- Other
Applications
- Veterinary Clinics
- Veterinary Hospitals
- For Retail
- Others
Companies covered
- Zoetis
- Merck & Co
- Medtronic
- Lilly
- Baxter
- Norbrook Laboratories
- Halyard
- Forest Laboratories
- Endo International
- Elanco
- Ceva Sante Animale
- Bostonscientific
- Boehringer Ingelheim
- Bayer Pharma AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Injected Veterinary Pain Management Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Injected Veterinary Pain Management Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Injected Veterinary Pain Management Drugs Market by Type
- 1.3.1 Sedatives
- 1.3.2 Local Anesthetics
- 1.3.3 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
- 1.3.4 Opioids
- 1.3.5 α2-Adrenergic Agonists
- 1.3.6 Other
- 1.4 Global Injected Veterinary Pain Management Drugs Market Size by Type
- 1.4.1 Global Injected Veterinary Pain Management Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Injected Veterinary Pain Management Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Injected Veterinary Pain Management Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Injected Veterinary Pain Management Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Injected Veterinary Pain Management Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Injected Veterinary Pain Management Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Injected Veterinary Pain Management Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Injected Veterinary Pain Management Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Injected Veterinary Pain Management Drugs Industry Trends
- 2.2 Injected Veterinary Pain Management Drugs Industry Drivers
- 2.3 Injected Veterinary Pain Management Drugs Industry Opportunities and Challenges
- 2.4 Injected Veterinary Pain Management Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Injected Veterinary Pain Management Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Injected Veterinary Pain Management Drugs Sales (2021-2026)
- 3.3 Global Top Players by Injected Veterinary Pain Management Drugs Price (2021-2026)
- 3.4 Global Injected Veterinary Pain Management Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Injected Veterinary Pain Management Drugs Major Company Production Sites & Headquarters
- 3.6 Global Injected Veterinary Pain Management Drugs Company, Product Type & Application
- 3.7 Global Injected Veterinary Pain Management Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Injected Veterinary Pain Management Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Injected Veterinary Pain Management Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Injected Veterinary Pain Management Drugs Tier 1, Tier 2, and Tier 3
4 Injected Veterinary Pain Management Drugs Regional Status and Outlook
- 4.1 Global Injected Veterinary Pain Management Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Injected Veterinary Pain Management Drugs Historic Market Size by Region
- 4.2.1 Global Injected Veterinary Pain Management Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Injected Veterinary Pain Management Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Injected Veterinary Pain Management Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Injected Veterinary Pain Management Drugs Forecasted Market Size by Region
- 4.3.1 Global Injected Veterinary Pain Management Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Injected Veterinary Pain Management Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Injected Veterinary Pain Management Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Injected Veterinary Pain Management Drugs by Application
- 5.1 Injected Veterinary Pain Management Drugs Market by Application
- 5.1.1 Veterinary Clinics
- 5.1.2 Veterinary Hospitals
- 5.1.3 For Retail
- 5.1.4 Others
- 5.2 Global Injected Veterinary Pain Management Drugs Market Size by Application
- 5.2.1 Global Injected Veterinary Pain Management Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Injected Veterinary Pain Management Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Injected Veterinary Pain Management Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Injected Veterinary Pain Management Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Injected Veterinary Pain Management Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Injected Veterinary Pain Management Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Injected Veterinary Pain Management Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Injected Veterinary Pain Management Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zoetis
- 6.1.1 Zoetis Company Information
- 6.1.2 Zoetis Business Overview
- 6.1.3 Zoetis Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zoetis Injected Veterinary Pain Management Drugs Product Portfolio
- 6.1.5 Zoetis Recent Developments
- 6.2 Merck & Co
- 6.2.1 Merck & Co Company Information
- 6.2.2 Merck & Co Business Overview
- 6.2.3 Merck & Co Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck & Co Injected Veterinary Pain Management Drugs Product Portfolio
- 6.2.5 Merck & Co Recent Developments
- 6.3 Medtronic
- 6.3.1 Medtronic Company Information
- 6.3.2 Medtronic Business Overview
- 6.3.3 Medtronic Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Medtronic Injected Veterinary Pain Management Drugs Product Portfolio
- 6.3.5 Medtronic Recent Developments
- 6.4 Lilly
- 6.4.1 Lilly Company Information
- 6.4.2 Lilly Business Overview
- 6.4.3 Lilly Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Lilly Injected Veterinary Pain Management Drugs Product Portfolio
- 6.4.5 Lilly Recent Developments
- 6.5 Baxter
- 6.5.1 Baxter Company Information
- 6.5.2 Baxter Business Overview
- 6.5.3 Baxter Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Baxter Injected Veterinary Pain Management Drugs Product Portfolio
- 6.5.5 Baxter Recent Developments
- 6.6 Norbrook Laboratories
- 6.6.1 Norbrook Laboratories Company Information
- 6.6.2 Norbrook Laboratories Business Overview
- 6.6.3 Norbrook Laboratories Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Norbrook Laboratories Injected Veterinary Pain Management Drugs Product Portfolio
- 6.6.5 Norbrook Laboratories Recent Developments
- 6.7 Halyard
- 6.7.1 Halyard Company Information
- 6.7.2 Halyard Business Overview
- 6.7.3 Halyard Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Halyard Injected Veterinary Pain Management Drugs Product Portfolio
- 6.7.5 Halyard Recent Developments
- 6.8 Forest Laboratories
- 6.8.1 Forest Laboratories Company Information
- 6.8.2 Forest Laboratories Business Overview
- 6.8.3 Forest Laboratories Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Forest Laboratories Injected Veterinary Pain Management Drugs Product Portfolio
- 6.8.5 Forest Laboratories Recent Developments
- 6.9 Endo International
- 6.9.1 Endo International Company Information
- 6.9.2 Endo International Business Overview
- 6.9.3 Endo International Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Endo International Injected Veterinary Pain Management Drugs Product Portfolio
- 6.9.5 Endo International Recent Developments
- 6.10 Elanco
- 6.10.1 Elanco Company Information
- 6.10.2 Elanco Business Overview
- 6.10.3 Elanco Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Elanco Injected Veterinary Pain Management Drugs Product Portfolio
- 6.10.5 Elanco Recent Developments
- 6.11 Ceva Sante Animale
- 6.11.1 Ceva Sante Animale Company Information
- 6.11.2 Ceva Sante Animale Business Overview
- 6.11.3 Ceva Sante Animale Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Ceva Sante Animale Injected Veterinary Pain Management Drugs Product Portfolio
- 6.11.5 Ceva Sante Animale Recent Developments
- 6.12 Bostonscientific
- 6.12.1 Bostonscientific Company Information
- 6.12.2 Bostonscientific Business Overview
- 6.12.3 Bostonscientific Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Bostonscientific Injected Veterinary Pain Management Drugs Product Portfolio
- 6.12.5 Bostonscientific Recent Developments
- 6.13 Boehringer Ingelheim
- 6.13.1 Boehringer Ingelheim Company Information
- 6.13.2 Boehringer Ingelheim Business Overview
- 6.13.3 Boehringer Ingelheim Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Boehringer Ingelheim Injected Veterinary Pain Management Drugs Product Portfolio
- 6.13.5 Boehringer Ingelheim Recent Developments
- 6.14 Bayer Pharma AG
- 6.14.1 Bayer Pharma AG Company Information
- 6.14.2 Bayer Pharma AG Business Overview
- 6.14.3 Bayer Pharma AG Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Bayer Pharma AG Injected Veterinary Pain Management Drugs Product Portfolio
- 6.14.5 Bayer Pharma AG Recent Developments
7 North America by Country
- 7.1 North America Injected Veterinary Pain Management Drugs Sales by Country
- 7.1.1 North America Injected Veterinary Pain Management Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Injected Veterinary Pain Management Drugs Sales by Country (2021-2026)
- 7.1.3 North America Injected Veterinary Pain Management Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Injected Veterinary Pain Management Drugs Market Size by Country
- 7.2.1 North America Injected Veterinary Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Injected Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Injected Veterinary Pain Management Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Injected Veterinary Pain Management Drugs Sales by Country
- 8.1.1 Europe Injected Veterinary Pain Management Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Injected Veterinary Pain Management Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Injected Veterinary Pain Management Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Injected Veterinary Pain Management Drugs Market Size by Country
- 8.2.1 Europe Injected Veterinary Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Injected Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Injected Veterinary Pain Management Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Injected Veterinary Pain Management Drugs Sales by Country
- 9.1.1 Asia-Pacific Injected Veterinary Pain Management Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Injected Veterinary Pain Management Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Injected Veterinary Pain Management Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Injected Veterinary Pain Management Drugs Market Size by Country
- 9.2.1 Asia-Pacific Injected Veterinary Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Injected Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Injected Veterinary Pain Management Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Injected Veterinary Pain Management Drugs Sales by Country
- 10.1.1 South America Injected Veterinary Pain Management Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Injected Veterinary Pain Management Drugs Sales by Country (2021-2026)
- 10.1.3 South America Injected Veterinary Pain Management Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Injected Veterinary Pain Management Drugs Market Size by Country
- 10.2.1 South America Injected Veterinary Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Injected Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Injected Veterinary Pain Management Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Injected Veterinary Pain Management Drugs Sales by Country
- 11.1.1 Middle East and Africa Injected Veterinary Pain Management Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Injected Veterinary Pain Management Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Injected Veterinary Pain Management Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Injected Veterinary Pain Management Drugs Market Size by Country
- 11.2.1 Middle East and Africa Injected Veterinary Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Injected Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Injected Veterinary Pain Management Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Injected Veterinary Pain Management Drugs Value Chain Analysis
- 12.1.1 Injected Veterinary Pain Management Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Injected Veterinary Pain Management Drugs Production Mode & Process
- 12.2 Injected Veterinary Pain Management Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Injected Veterinary Pain Management Drugs Distributors
- 12.2.3 Injected Veterinary Pain Management Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst